Archives
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
Tetraethylammonium Chloride: K+ Channel Research
2026-09-14
Tetraethylammonium chloride (TEAC) is a pore-blocking tool for studying potassium-channel ion conduction, vascular responses, and ganglionic transmission. The B7262 product is supplied as a solid at 98% purity, with product-reported aqueous, ethanolic, and DMSO solubility data.
-
Benzyl-activated Streptavidin Magnetic Beads (SKU: K1301)
2026-09-14
Benzyl-activated Streptavidin Magnetic Beads (SKU: K1301) provide a magnetically separable surface for capturing biotinylated proteins, nucleic acids, peptides, antibodies, sugars, and other targets from complex samples. They are appropriate for capture, purification, immunoprecipitation, and interaction workflows, but require validation for target-specific recovery, nonspecific binding, elution compatibility, and live-cell applications.
-
SNORA38B, GAB2/AKT/mTOR, and NSCLC Immunotherapy
2026-09-13
The reference study identifies SNORA38B as an oncogenic small nucleolar RNA that links E2F1-dependent GAB2 transcription to AKT/mTOR signaling and an immunosuppressive tumor microenvironment in non-small cell lung cancer. Its genetic and pharmacologic experiments suggest that SNORA38B inhibition may both restrain tumor growth and improve sensitivity to immune checkpoint blockade.
-
Verapamil HCl: Workflows for Calcium Signaling
2026-09-12
Build reproducible calcium-signaling experiments with Verapamil HCl across myeloma apoptosis, inflammatory arthritis, and bone-turnover models. This guide connects practical assay design with the emerging Txnip-centered osteoporosis mechanism while emphasizing controls, formulation, and interpretation limits.
-
(-)-Blebbistatin for Mechanobiology Workflows
2026-09-11
Use (-)-Blebbistatin to separate non-muscle myosin II–dependent force generation from receptor signaling, cell movement, and tissue remodeling. This workflow-focused guide connects reversible actin–myosin inhibition with traction-force, shear-stress, migration, cardiac, and developmental assays.
-
BCA Protein Quantification Kit: K4102 Guide
2026-09-11
The Bicinchoninic Acid Assay (BCA) Protein Quantification Kit K4102 supports sensitive total-protein measurement in dilute samples, including many detergent-containing preparations and cell lysates. It is intended for scientific research and sample normalization, not diagnostic, clinical, or medical testing.
-
Benzyl-activated Streptavidin Magnetic Beads
2026-09-10
Benzyl-activated Streptavidin Magnetic Beads (SKU: K1301) provide a magnetically recoverable surface for capturing biotinylated proteins, peptides, antibodies, nucleic acids, sugars, and related molecules from complex samples. They are appropriate for biotin-dependent purification, immunoprecipitation, interaction assays, and screening workflows, but require optimization when samples contain hydrophobic interferents, high nonspecific background, or targets that are not biotinylated.
-
Sunitinib Workflows for RTK and Glioma Research
2026-09-10
Sunitinib is a practical multi-targeted receptor tyrosine kinase inhibitor for linking RTK blockade to angiogenesis, apoptosis, and genotype-dependent glioma vulnerability. This workflow combines solution handling, dose-response design, ATRX-stratified assays, and orthogonal readouts for renal cell carcinoma, nasopharyngeal carcinoma, and tumor–endothelial models.
-
Leucomycin (Kitasamycin): From Ribosome to Translation
2026-09-09
Leucomycin, also known as kitasamycin, is best understood as a composition-aware macrolide research tool rather than a simple single-analyte antibiotic. This thought-leadership guide connects ribosomal mechanism, historical susceptibility evidence, assay design, resistance characterization, and translational decision-making.
-
AMG 9810 Workflows for TRPV1 Antagonist Studies
2026-09-09
AMG 9810 enables selective dissection of TRPV1-driven calcium and CGRP responses across sensory-neuron models. This practical guide combines antagonist assay design with metabolic-stress controls so researchers can distinguish receptor signaling from broader cellular stress effects.
-
Bismuth Subsalicylate GI Assay Workflows
2026-09-08
Build more interpretable gastrointestinal disorder research workflows with Bismuth Subsalicylate, combining prostaglandin-pathway experiments with orthogonal membrane-integrity and apoptosis measurements. The key advantage is not a claim of superior potency, but controlled handling of an insoluble bismuth salt and clear separation of compound exposure from downstream cell-state effects.
-
TH287 MTH1 Inhibitor for Radiosensitization
2026-09-08
TH287 converts oxidized nucleotide stress into a tractable cancer-cell radiosensitization workflow. This bench guide translates schedule-dependent CRPC evidence into compound handling, assay design, mechanistic readouts, and troubleshooting decisions.
-
PKH26 Red Fluorescent Cell Linker Kit Guide
2026-09-07
The PKH26 Red Fluorescent Cell Linker Kit labels cell membrane lipid regions with a stable red fluorescent signal for cell tracing and proliferation-oriented assays. It is intended for membrane labeling in vitro and in vivo, not for intracellular targets or non-membrane labeling, and experimental conditions should be optimized without assuming unprovided concentrations or incubation times.
-
Griseofulvin Workflow for Microtubule Assays
2026-09-07
Griseofulvin is a DMSO-soluble microtubule associated inhibitor suited to fungal growth, mitotic phenotyping, and mechanism-focused assay development. This guide connects practical formulation and exposure controls with the tiered flow-cytometry strategy reported for distinguishing tubulin-driven aneugenic mechanisms.
-
Nintedanib (BIBF 1120) Research Workflows
2026-09-05
Build reproducible Nintedanib assays around receptor biology, ATRX-aware glioma stratification, and orthogonal measures of apoptosis and angiogenesis. This guide distinguishes evidence-supported starting conditions from optimization choices for cancer, fibrosis, and translational model development.